Who owns Q32 BIO INC COM?
- Ticker: QTTB
- CUSIP Number: 746964105
Tip: Access positions for across all investors
Analyze quarterly positions in Q32 Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Q32 Bio stock
Who bought or sold Q32 BIO INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 2.3M | $15M | 0% | Mar 2026 |
|
| Atlas Venture Life Science Advisors | 2.1M | $6.9M | 0% | Dec 2025 |
|
| Opaleye Management | 1.3M | $8.1M | 489% | Mar 2026 |
|
| Carlyle | 1.1M | $7.1M | 0% | Mar 2026 |
|
| Acorn Capital Advisors | 493k | $1.6M | -39% | Dec 2025 |
|
| Vanguard Group | 321k | $1.1M | 9% | Dec 2025 |
|
| Arch Venture Corp | 321k | $2.1M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 306k | $2.0M | 100% | Mar 2026 |
|
| Mackenzie Financial | 246k | $1.6M | 100% | Mar 2026 |
|
| Sanofi | 244k | $1.6M | 0% | Mar 2026 |
|
| Acadian Asset Management | 173k | $1.1M | 257% | Mar 2026 |
|
| Monimus Capital Management | 134k | $862k | 100% | Mar 2026 |
|
| Geode Capital Management | 118k | $759k | 11% | Mar 2026 |
|
| Pfizer | 102k | $737k | -63% | Mar 2026 |
|
| Renaissance Technologies | 100k | $331k | 111% | Dec 2025 |
|
| BlackRock | 86k | $553k | 44% | Mar 2026 |
|
| Jane Street | 66k | $421k | 159% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 50k | $321k | 100% | Mar 2026 |
|
| Two Sigma Investments | 42k | $272k | -10% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 35k | $225k | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 35k | $225k | 75% | Mar 2026 |
|
| Affinity Asset Advisors | 28k | $92k | 0% | Dec 2025 |
|
| Northern Trust | 25k | $83k | -22% | Dec 2025 |
|
| State Street Corporation | 21k | $71k | 0% | Dec 2025 |
|
| Cetera Investment Advisers | 21k | $133k | 100% | Mar 2026 |
|
| XTX Topco | 20k | $68k | 100% | Dec 2025 |
|
| Citadel Advisors | 16k | $99k | -66% | Mar 2026 |
|
| Morgan Stanley | 9.6k | $61k | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 4.6k | $30k | 0% | Mar 2026 |
|
| FMR | 3.4k | $11k | -79% | Dec 2025 |
|
| Royal Bank of Canada | 2.7k | $18k | 161% | Mar 2026 |
|
| Federated Investors | 2.3k | $15k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 1.9k | $12k | 100% | Mar 2026 |
|
| Global Retirement Partners | 1.5k | $5.0k | -70% | Dec 2025 |
|
| SRS Capital Advisors | 1.1k | $7.4k | 3% | Mar 2026 |
|
| Tower Research Capital | 976.00 | $3.2k | -85% | Dec 2025 |
|
| Rockefeller Capital Management | 577.00 | $3.7k | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 500.00 | $1.7k | 100% | Dec 2025 |
|
| Russell Investments | 454.00 | $2.9k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 303.00 | $1.9k | -2% | Mar 2026 |
|
| UBS Group | 270.00 | $1.7k | -98% | Mar 2026 |
|
| NISA Investment Advisors | 166.00 | $1.1k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 132.00 | $436.999200 | -29% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 111.00 | $712.997400 | 270% | Mar 2026 |
|
| SBI Securities | 104.00 | $668.002400 | -34% | Mar 2026 |
|
| Hanson McClain Advisors | 98.00 | $325.997000 | -84% | Dec 2025 |
|
| Wells Fargo & Company | 84.00 | $539.002800 | 100% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 70.00 | $449.477000 | 0% | Mar 2026 |
|
| CWM | 54.00 | $0 | -75% | Dec 2025 |
|
| Group One Trading | 34.00 | $218.001200 | 0% | Mar 2026 |
|
| Barclays | 19.00 | $63.000200 | -98% | Dec 2025 |
|
| Harbour Investments | 11.00 | $70.999500 | 0% | Mar 2026 |
|
| AdvisorNet Financial | 2.00 | $13.000000 | 0% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $6.000000 | 0% | Mar 2026 |
|
Who sold out of Q32 Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Dec 2025 | 51k | $170k |
| Monaco Asset Management SAM | Dec 2025 | 51k | $169k |
| Hrt Financial | Dec 2025 | 25k | $81k |
| Scientech Research | Dec 2025 | 16k | $52k |
| Jpmorgan Chase & Co | Sep 2025 | 4.00 | $8.000000 |